Дисфункция миокарда у больных циррозом печени: клиническое значение предшественника мозгового натрийуретического пептида Medline.ru - медико-биологический информационный портал Медлайн.ру

1. Воробьев Л.П., Маев И.В., Андреев Н.Г. Взаимосвязь легочного кровотока, общей гемодинамики и портального кровообращения у больных хроническим гепатитом и циррозом печени. // Кровообращение.-1991.-Т.24.-2.-С.39-43.

2. Bosch J., Garcia-Pagan J.C. Complications of cirrhosis. I. Portal hypertension. // J Hepatol.-2000.-Vol.32.-P.141-156.

3. Fernandez-Sola J., Estruch R., Grau J.M. et al. The relation of alcoholic myopathy to cardiomyopathy. // Ann Intern Med.-1994.-Vol.120.-P.529-536.

4. Guillo P., Mansourati J., Maheu B. et al. Long-term prognosis in patients with alcoholic cardiomyopathy and severe heart failure after total abstinence. // Am J Cardiol.-1997.Vol.79.-P.1276-1278. 5. Henriksen J.H., Gotze J.P., Fuglsang S. et al. Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. // Gut.-2003.-Vol.52.-P.1511-1517.

6. Huonker M., Schumacher Y.O., Ochs A. et al. Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt. // Gut.-1999.-Vol.44.-743-748.

7. Iwao T., Oho K., Nakano R. et al. High plasma cardiac natriuretic peptides associated with enhanced cyclic guanosine monophosphate production in preascitic cirrhosis. // J. Hepatol.-2000.-Vol.32.-P.426-433.

8. Kowalski H.J., Abelmann W.H. Cardiac output in Laennec cirrhosis.// J. Clin. Invest.1953.-Vol.32.-P.1356-1358.

9. LaVilla G., Romanelli R.G., Casini Raggi V. et al. Plasma levels of brain natriuretic peptide in patients with cirrhosis. // Hepatology.-1992.-Vol.16.-P.156-161.

10. Lebrec D., Giuily N., Hadenque A. et al. Transjugular intrahepatic portosystemic shunt: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. // J. Hepatol.-1996.-Vol.25.-P.135-144.

11. Liu H., Ma Z., Lee S.S. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. // Gastroenterology.-2000.-Vol.118.-P.937-944.

12. Ma Z., Lee S.S. Cirrhotic cardiomyopathy: Getting to the heart of the matter. // Hepatology.-1996.-Vol.24.-P.451-459.

13. Mair J. Role of Cardiac Natriuretic Peptide Testing in Heart Failure. // Clinical Chemistry.-2002.-Vol.48.-P.977-978.

14. Moller S., Henriksen J.H. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. // Heart.-2002.-Vol.8.-P.9-15.

15. Moller S., Sondergaard L., Mogelvang J. et al. Decreased right heart blood volume determined by magnetic resonance imaging: evidence of central underfilling in cirrhosis. // Hepatology.-1995.-Vol.22.-P.472-478.

16. Mueller T., Gegenhuber A., Poelz W., Haltmayer M. Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease. // Clin Chim Acta.-2004.-Vol.341.-P.41-48.

17. Park S.H., Shub C., Nobrega T.P. et al. Two dimensional echocardiographic calculation of left ventricular mass as recommended by the American Society of Echocardiography correlation with autopsy and M-mode echocardiography. // J Am Soc Echocardiogr.1996.-Vol.9.-P.119-128.

18. Pozzi M., Carugo S., Boari G. et al. Functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. // Hepatology.-1997.-Vol.26.-P.1131-1137.

19. Rayes N., Bechstein, W.O., Keck H. et al. Causes of death after liver transplantation: an analysis of 41 cases in 382 patients. // Zentralbl. Chir.-1995.-Vol.120.-P.435-438.

20. Valeriano V., Funaro S., Lionetti R. et al. Modification of cardiac function in cirrhotic patients with and without ascites. // Am J Gastroenterol.-2000.-Vol.95.-P.3200-3205.

21. Wilke A., Funck R., Rupp H., Brilla C.G. Effects of the renin-angiotensin-aldosterone system on the cardiac interstitium in heart failure. // Basic Res. Cardiol.-1996.Vol.91(suppl. 2).-P.79-84.

22. Wong F., Siu S., Liu P., Blendis L.M. Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis? // Clinical Science.-2001.-Vol.101.-P.621-628.

23. Wong F., Liu P., Lilly L., Bomzon A., Blendis L. The role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis. // Clin. Sci.-1999.-Vol.97.-P.259-267.